Evolus (EOLS) Revenue (2019 - 2026)
Evolus' (EOLS) quarterly Revenue came in at $73.1 million in Q1 2026, up 6.74% YoY from $68.5 million in Q1 2025, and down 19.01% on a QoQ basis from $90.3 million in Q4 2025.
Evolus (EOLS) Revenue (2019 - 2026) Analysis & Trends
Evolus (EOLS) has 8 years of Revenue data on file, last reported at $73.1 million in Q1 2026.
- Quarterly Revenue rose 6.74% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $301.8 million (up 9.56% YoY) and the FY2025 annual result came in at $297.2 million, up 11.61% from the prior year.
- Revenue slipped to $73.1 million in Q1 2026, from $90.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $90.3 million in Q4 2025 to a low of $33.9 million in Q3 2022.
- A 5-year average of $58.1 million and a median of $61.0 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue jumped 177.0% — and 2025, when it rose 3.7%.
- Tracing EOLS's Revenue over 5 years: stood at $43.6 million in 2022, then jumped by 39.76% to $61.0 million in 2023, then climbed by 29.42% to $78.9 million in 2024, then gained by 14.38% to $90.3 million in 2025, then decreased by 19.01% to $73.1 million in 2026.
- The last three Revenue figures came in at $73.1 million (Q1 2026), $90.3 million (Q4 2025), and $69.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Evolus | 553.15 Mn | 507.98 Mn | 57.18 Mn | 84.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.08 Mn |
| Mar 31, 2026 | 73.14 Mn |
| Dec 31, 2025 | 90.30 Mn |
| Sep 30, 2025 | 68.97 Mn |
| Jun 30, 2025 | 69.39 Mn |
| Mar 31, 2025 | 68.52 Mn |
| Dec 31, 2024 | 78.95 Mn |
| Sep 30, 2024 | 61.09 Mn |
| Jun 30, 2024 | 66.91 Mn |
| Mar 31, 2024 | 59.33 Mn |
| Dec 31, 2023 | 61.00 Mn |
| Sep 30, 2023 | 50.02 Mn |
| Jun 30, 2023 | 49.35 Mn |
| Mar 31, 2023 | 41.72 Mn |
| Dec 31, 2022 | 43.65 Mn |
| Sep 30, 2022 | 33.90 Mn |
| Jun 30, 2022 | 37.16 Mn |
| Mar 31, 2022 | 33.91 Mn |
| Dec 31, 2021 | 34.66 Mn |
| Sep 30, 2021 | 26.68 Mn |